Table 4.

Comparison of expression levels of IFNG and IFNG-AS1 genes in tumoral tissue of breast cancer patients between clinicopathological-based categories (mean and SD values of (E^CT_B2M/E^CT_{target gene}) are presented)

	IFNG	P value	IFNG-AS1	P value
Age
Pre-menopause vs. post-menopause	0.02 (0.04) vs. 0.03 (0.04)	0.59	0.01 (0.01) vs. 0.01 (0.02)	0.78
ER status
ER(+) vs. ER(−)	0.03 (0.05) vs. 0.02 (0.01)	0.66	0.01 (0.02) vs. 0.01 (0.01)	0.97
PR status
PR(+) vs. PR(−)	0.03 (0.05) vs. 0.02 (0.02)	0.74	0.01 (0.02) vs. 0.01 (0.01)	0.92
HER2 status
HER2(+) vs. HER2(−)	0.009 (0.01) vs. 0.03 (0.05)	0.01	0.01 (0.01) vs. 0.01 (0.02)	0.57
Tumor grade
Grade 1 vs. 2	0.06 (0.08) vs. 0.01 (0.03)	0.03	0.02 (0.02) vs. 0.01 (0.02)	0.73
Grade 1 vs. 3	0.06 (0.08) vs. 0.02 (0.02)	0.1	0.02 (0.02) vs. 0.01 (0.01)	0.69
Grade 2 vs. 3	0.01 (0.03) vs. 0.02 (0.02)	0.89	0.01 (0.02) vs. 0.01 (0.01)	0.99